TrialThe Journal of allergy and clinical immunology2020

Development of a novel Ara h 2 hypoallergen with no IgE binding or anaphylactogenic activity.

Angelika Tscheppe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.